Okay, so Pfizer’s acting like they just invented the nose game or something. $92 billion market? Like, sure, that sounds huge, but come on. Nasal drug delivery? It’s basically medicine playing peek-a-boo with your nostrils. I can barely handle my ex’s texts, not some “innovative” brain delivery system through my nose. Ew, stop.
Apparently, people are all about “non-invasive methods” now. Like, nobody wants a giant needle in their arm so Pfizer’s like, “Hey, sniff this!” But let’s be real, if I wanted to smell weird chemicals every day, I’d just hang around my last toxic ex. And newsflash, “overcoming permeability challenges” is pharma-speak for “we’re kinda stuck but trying not to mess up.”
Meanwhile, GSK is also in this sniff-fest, trying to be cool in the nose club. But can you imagine snorting your meds like it’s a bad nightclub? Not cute, Pfizer, not cute. The whole thing feels like a bad breakup—promises big but leaves you sniffing for real answers.
If you’re into healthcare gossip, check out this healthcare roast for more drama. Or maybe you wanna stalk some finance chaos? Try this Morgan Stanley roast.
Honestly, this Pfizer nose stuff? I can’t. Like, stick to the pills and leave the sniffing for perfumes or sadness, okay?
Think you’re wired for chaos? Tap here.